[New major anti-infectious chemotherapy: sulfamethoxazole-trimethoprim association. Bacteriological and clinical study].
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects*; D001431:Bacteriological Techniques; D002648:Child; D002675:Child, Preschool; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008581:Meningitis / Q000188:drug therapy; D011743:Pyrimidines / Q000627:therapeutic use*; D012141:Respiratory Tract Infections / Q000188:drug therapy; D012480:Salmonella Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D011743:Pyrimidines; D013420:Sulfamethoxazole
Une nouvelle chimiothérapie anti-infectieuse majeure: l'association sulfaméthoxazole-triméthoprime. Etude bactériologique et clinique.